Article PDF
References
Gomez-Raposo C, Mendiola M, Barriuso J et al (2009) Angiogenesis and ovarian cancer. Clin Transl Oncol 11:564–571
Lyden D, Young AZ, Zagzag D et al (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401:670–677
Jankovic V, Ciarrocchi A, Boccuni P et al (2007) Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc Natl Acad Sci U S A 104:1260–1265
Ouyang XS, Wang X, Ling MT et al (2002) Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis 23:721–725
Di K, Ling MT, Tsao SW et al (2006) Id-1 modulates senescence and TGF-beta1 sensitivity in prostate epithelial cells. Biol Cell 98:523–533
Gupta GP, Perk J, Acharyya S et al (2007) ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci U S A 104:19506–19511
Lin JC, Chang SY, Hsieh DS et al (2005) The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells. Oncol Rep 13:983–988
Zhang X, Ling MT, Wang X et al (2006) Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Int J Cancer 118:2072–2081
Schindl M, Schoppmann SF, Strobel T et al (2003) Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res 9:779–785
de Candia P, Solit DB, Giri D et al (2003). Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc Natl Acad Sci U S A 100:12337–12342
Uehara N, Chou YC, Galvez JJ et al (2003) Id-1 is not expressed in the luminal epithelial cells of mammary glands. Breast Cancer Res 5:R25–R29
Perk J, Gil-Bazo I, Chin Y et al (2006) Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res 66:10870–10877
Gil-Bazo I, Ponz-Sarvise M, Rosell D et al (2009) Use of inhibitor of differentiation-1 (Id1) expression (exp) to discriminate good prognosis (GP) from poor prognosis (PP) prostate cancer (PCa). J Clin Oncol [Genitourinary Cancers Symposium] Abstract 12
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gil-Bazo, I., Ponz-Sarvisé, M., Panizo-Santos, Á. et al. Id-1 expression and prognosis in cancer: do antibodies matter?. Clin Transl Oncol 12, 69 (2010). https://doi.org/10.1007/s12094-010-0470-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-010-0470-3